Volume 20, Number 7—July 2014
Diphtheria-like Disease Caused by Toxigenic Corynebacterium ulcerans Strain
To the Editor: Toxigenic Corynebacterium ulcerans is an increasingly reported cause of diphtheria in the United Kingdom and is often associated with a zoonotic origin (1,2). Here, we report a case of diphtheria caused by toxigenic C. ulcerans in a woman, 51 years of age, from Scotland, UK, who was admitted to a hospital in August 2013 with a swollen, sore throat and a gray-white membrane over the pharyngeal surface. The patient had returned from a 2-week family holiday in the state of Florida, United States, before the admission and also reported recent treatment of a pet dog for pharyngitis. The patient was believed to have been vaccinated against diphtheria during childhood. She was immediately admitted to an isolation ward and treated with a combination of clindamycin, penicillin, and metronidazole.
Microscopic examination of the throat biofilm (collected by using a swab) showed gram-positive bacilli; swab samples from the exudative membrane and throat produced small, black colonies indicative of Corynebacterium spp. on Hoyle medium. Further efforts to identify the strain by using VITEK MS and VITEK2 ANC card systems (bioMérieux, Marcy l’Etoile, France) to evaluate the swab samples suggested that the infection was caused by either C. ulcerans or C. pseudotuberculosis (50% CI). The isolate detected from this process was sent to the Streptococcus and Diphtheria Reference Unit, Public Health England, Colindale, UK, and was confirmed to be a toxigenic C. ulcerans strain that we designated RAH1. Throat swab samples were collected from family members of the patient and were negative for C. ulcerans. The family dog was not tested for presence of the organism, although it is known that C. ulcerans infections are often of a zoonotic nature (1,2). After treatment, the patient made a full recovery.
Toxigenic C. ulcerans can produce both diphtheria-like and Shiga-like toxins (3); to identify the genetic basis of toxin production and other potential virulence factors in this strain, a whole genome sequencing approach was applied to the isolate. The genome was sequenced by using an Ion PGM System (Thermo Fischer Scientific, Loughborough, Leicestershire, UK) and resulting reads (2,965,044 reads, ≈90x coverage. Data are available on GenBank SRA: high-throughput DNA and RNA sequence read archive (http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=search_obj, accession no.: SRR1145126) and were mapped onto the published genome sequences of a Shiga-like toxin–producing clinical isolate 809, asymptomatic canine strain BR-AD22 (3), and diphtheria-like toxin–producing strain 0102 (4). Most of the previously identified virulence genes (3,4) were present in the patient isolate (Table). The tox gene, encoding diphtheria toxin, was present, which verified the diphtheria-like disease in the patient. The rbp gene, responsible for Shiga toxin–like ribosome-binding protein, was absent. However, strain RAH1 also possessed the venom serine protease gene (vsp2), which, in C. ulcerans strain 809, has been implicated in the increased virulence in humans. The tox gene was present in a prophage that showed similarities to ΦCULC809I (3) and ΦCULC0102-I (4). Genome-based phylogenetic analysis of the RAH1 strain (ClonalFrame analysis ) and strains 809, BR-AD22, and 0102 indicates a much wider phylogenetic diversity of C. ulcerans strains than previously appreciated (data not shown).
This case raises the issue of waning vaccine protection in older patients and suggests that toxin-mediated corynebacterial disease remains a threat to public health. The declining costs of next-generation sequencing and availability of easy-to-handle bioinformatics tools emphasize the suitability of deep-sequencing technology for rapid diagnostics and for the development of high-resolution genotyping. It is time for the wider introduction of this technology into public health investigations.
- Taylor J, Saveedra-Campos M, Harwood D, Pritchard G, Raphaely N, Kapadia S, Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010. Euro Surveill. 2010;15:••• .
- Wagner KS, White JM, Crowcroft NS, De Martin S, Mann G, Efstratiou A. Diphtheria in the United Kingdom, 1986–2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect. 2010;138:1519–30 .
- Trost E, Al-Dilaimi A, Papavasiliou P, Schneider J, Viehoever P, Burkovski A, Comparative analysis of two complete Corynebacterium ulcerans genomes and detection of candidate virulence factors. BMC Genomics. 2011;12:383 .
- Sekizuka T, Yamamoto A, Komiya T, Kenri T, Takeuchi F, Shibayama K, Corynebacterium ulcerans 0102 carries the gene encoding diphtheria toxin on a prophage different from the C. diphtheriae NCTC 13129 prophage. BMC Microbiol. 2012;12:72 .
- Didelot X, Falush D. Inference of bacterial microevolution using multilocus sequence data. Genetics. 2007;175:1251–66 .
- Table. Virulence genes associated with Corynebacterium ulcerans present in strain RAH1 isolated from patient with diphtheria-like disease, 2013, United Kingdom
Keywords: diphtheria, Corynebacterium, toxin, toxigenic, bacteria, antibiotic, antimicrobial, zoonoses, Florida, United States, Scotland, United Kingdom
Suggested citation for this article: Sangal V, Nieminen L, Weinhardt B, Raeside J, Tucker NP, et al. Diphtheria-like disease caused by toxigenic Corynebacterium ulcerans strain [letter]. Emerg Infect Dis. 2014 Jul [date cited]. http://dx.doi.org/10.3201/eid2007.140216
Please use the form below to submit correspondence to the authors or contact them at the following address:
Paul A. Hoskisson, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St, Glasgow, G4 0RE, Scotland, UK
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 18, 2014
- Page last updated: June 18, 2014
- Page last reviewed: June 18, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)